Imugene Limited (ASX:IMU)
Australia · Delayed Price · Currency is AUD 0.0540
-0.0040 (-6.90%)
Sep 11, 2026, 12:37 PM AEST
Imugene Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Other Revenue | 2.09 | 4.45 | 4.97 | 11.78 | 12.97 |
| 2.09 | 4.45 | 4.97 | 11.78 | 12.97 | |
Revenue Growth | -53.07% | -10.56% | -57.80% | -9.19% | 79.35% |
Gross Profit | 2.09 | 4.45 | 4.97 | 11.78 | 12.97 |
Selling, General & Admin | 31.86 | 27.82 | 59.91 | 20.43 | 14.06 |
Research & Development | 75.57 | 24.93 | 86.89 | 30.86 | 36.61 |
Operating Expenses | 107.42 | 52.75 | 146.79 | 51.29 | 50.67 |
Operating Income | -105.34 | -48.3 | -141.82 | -39.52 | -37.7 |
Interest Expense | -0.13 | -0.16 | -0.48 | -0.03 | -0.01 |
Interest & Investment Income | 0.49 | 2.08 | 4.52 | 1.88 | 0.19 |
Currency Exchange Gain (Loss) | -0.38 | -0.67 | -0.63 | -0.25 | -0.13 |
Other Non Operating Income (Expenses) | - | - | - | - | -0.11 |
EBT Excluding Unusual Items | -105.35 | -47.05 | -138.42 | -37.91 | -37.76 |
Gain (Loss) on Sale of Assets | 0.01 | -0.21 | -11.26 | -0 | -0.1 |
Pretax Income | -105.34 | -47.26 | -149.68 | -37.91 | -37.87 |
Net Income | -105.34 | -47.26 | -149.68 | -37.91 | -37.87 |
Net Income to Common | -105.34 | -47.26 | -149.68 | -37.91 | -37.87 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 326 | 219 | 208 | 185 | 166 |
Shares Outstanding (Diluted) | 326 | 219 | 208 | 185 | 166 |
Shares Change | 49.10% | 4.90% | 12.96% | 11.33% | 20.88% |
EPS (Basic) | -0.32 | -0.22 | -0.72 | -0.21 | -0.23 |
EPS (Diluted) | -0.32 | -0.22 | -0.72 | -0.21 | -0.23 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -44.74 | -83.12 | -108.8 | -31.47 | -31.11 |
Free Cash Flow Per Share | -0.14 | -0.38 | -0.52 | -0.17 | -0.19 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -5049.51% | -1086.60% | -2853.55% | -335.51% | -290.70% |
Profit Margin | -5049.45% | -1063.16% | -3011.66% | -321.92% | -291.98% |
Free Cash Flow Margin | -2144.66% | -1869.76% | -2189.12% | -267.21% | -239.83% |
EBITDA | -99.92 | -45.66 | -137.45 | -37.31 | -35.45 |
EBITDA Margin | - | - | - | - | -273.30% |
D&A For EBITDA | 5.42 | 2.64 | 4.38 | 2.2 | 2.26 |
EBIT | -105.34 | -48.3 | -141.82 | -39.52 | -37.7 |
EBIT Margin | - | - | - | - | -290.70% |